介质细胞干细胞衍生的亡体通过调节骨质细胞分化和功能来缓解膜骨破坏
Xiaoyan Li1, Yiyang Jiang1, Xu Liu1
1Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China.
International journal of oral science
|December 1, 2023
概括
介质细胞干细胞衍生的亡体通过抑制骨质细胞活性,显示出牙周炎的治疗潜力. 这些亡体提供miR-223-3p,减少骨质损失并提供一种新的治疗策略.
科学领域:
- 再生医学是一种再生医学.
- 口腔生物学 口腔生物学
- 细胞生物学 细胞生物学
背景情况:
- 牙周炎涉及骨质细胞过度活跃,导致牙周组织和骨质损失.
- 牙周炎的低氧环境会导致介质干细胞 (MSC) 亡.
- 从亡细胞中形成的亡体 (ABs) 正在成为潜在的治疗剂.
研究的目的:
- 研究MSC衍生的ABs对牙周炎的治疗作用.
- 阐明MSC衍生的ABs治疗作用的基础机制.
主要方法:
- 使用多过方法从低氧MSC培养物中分离ABs.
- 评估ABs对骨质细胞分化和骨再吸收的影响.
- 微RNA阵列分析以识别ABs中的关键微RNA.
- 对miRNA目标的验证 (例如,Itgb1) 和吞机制的调查 (例如,DC-STAMP).
主要成果:
- 来自MSC的ABs显著抑制了骨质细胞分化和膜骨再吸收.
- 富含ABs的miR-223-3p被确定为治疗效果的关键.
- 通过DC-STAMP介导的膜融合,AB被前骨质细胞吞,产生miR-223-3p并减弱骨质细胞功能.
结论:
- 来自MSC的AB显示为牙周炎治疗的有前途的治疗潜力.
- 该机制涉及DC-STAMP介导的吞和miR-223-3p转移,导致骨质细胞活性降低和骨质再吸收.
- 来自MSC的ABs代表了牙周炎的新和有效的治疗策略.
相关概念视频
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Phagocytosis of Apoptotic Cells
3.8K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.8K
Apoptosis
11.5K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.5K


